Cisplatin nanoliposomes for cancer therapy: AFM and fluorescence imaging of cisplatin encapsulation, stability, cellular uptake, and toxicity
- PMID: 16952256
- DOI: 10.1021/la0607499
Cisplatin nanoliposomes for cancer therapy: AFM and fluorescence imaging of cisplatin encapsulation, stability, cellular uptake, and toxicity
Abstract
Cisplatin is the most effective cytotoxic agent against many cancers. Its usage, however, is limited due to inefficient uptake by the target cells. A liposomal formulation of cisplatin is reported to partly overcome this limitation. Physicochemical characteristics of the liposome-cisplatin preparation, including its size, stability, encapsulation efficiency, and cytoplasmic internalization efficiency, play a significant role in an effective usage of liposomal formulations. We have used atomic force microscopy (AFM) to determine physicochemical characteristics of cisplatin-encapsulated liposomes, AFM and fluorescence microscopy to examine their cytoplasmic internalization, and Live/Dead assay to examine their cell toxicity. Nonencapsulated cisplatin is globular and 10-50 nm in size. AFM force-dissection and stiffness measurements show that cisplatin-encapsulated liposomes are significantly stiffer ( approximately 100%) and more stable than liposomes without encapsulated cisplatin. Cisplatin-encapsulated liposomes of approximately 250 nm diameter (nanoliposomes) are most efficiently internalized and induce cell toxicity in a time-dependent manner. Liposomes without cisplatin of similar dimensions, although internalized in the cell cytoplasm, do not induce cell toxicity.
Similar articles
-
Improved pharmacological profile of the lipophilic antitumor dichloro-(N-dodecyl)-propanediamine-platinum(II) complex after incorporation into pegylated liposomes.Anticancer Drugs. 2013 Feb;24(2):131-9. doi: 10.1097/CAD.0b013e3283599a34. Anticancer Drugs. 2013. PMID: 23011234
-
Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.Biomaterials. 2014 May;35(14):4297-309. doi: 10.1016/j.biomaterials.2014.01.035. Epub 2014 Feb 22. Biomaterials. 2014. PMID: 24565522
-
Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro.Int J Pharm. 2010 Apr 15;389(1-2):10-7. doi: 10.1016/j.ijpharm.2009.12.061. Epub 2010 Jan 7. Int J Pharm. 2010. PMID: 20060458
-
Atomic force microscopy: a tool to study the structure, dynamics and stability of liposomal drug delivery systems.Expert Opin Drug Deliv. 2009 Mar;6(3):305-17. doi: 10.1517/17425240902828312. Expert Opin Drug Deliv. 2009. PMID: 19327046 Review.
-
Clinical overview on Lipoplatin: a successful liposomal formulation of cisplatin.Expert Opin Investig Drugs. 2009 Aug;18(8):1197-218. doi: 10.1517/13543780903114168. Expert Opin Investig Drugs. 2009. PMID: 19604121 Review.
Cited by
-
Failure of Elevating Calcium Induces Oxidative Stress Tolerance and Imparts Cisplatin Resistance in Ovarian Cancer Cells.Aging Dis. 2016 May 27;7(3):254-66. doi: 10.14336/AD.2016.0118. eCollection 2016 May. Aging Dis. 2016. PMID: 27330840 Free PMC article.
-
Mechanical characterization of cervical squamous carcinoma cells by atomic force microscopy at nanoscale.Med Oncol. 2015 Mar;32(3):71. doi: 10.1007/s12032-015-0507-0. Epub 2015 Feb 19. Med Oncol. 2015. PMID: 25694045
-
Magnetic targeting of nanoparticles across the intact blood-brain barrier.J Control Release. 2012 Nov 28;164(1):49-57. doi: 10.1016/j.jconrel.2012.09.021. Epub 2012 Oct 10. J Control Release. 2012. PMID: 23063548 Free PMC article.
-
Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer.Bioimpacts. 2014;4(1):3-14. doi: 10.5681/bi.2014.011. Epub 2014 Mar 28. Bioimpacts. 2014. PMID: 24790893 Free PMC article. Review.
-
Multidimensional atomic force microscopy: a versatile novel technology for nanopharmacology research.AAPS J. 2010 Dec;12(4):716-28. doi: 10.1208/s12248-010-9232-y. Epub 2010 Oct 19. AAPS J. 2010. PMID: 20957528 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous